LNTH and GEHC Related Headlines

Go Back

Sep 24, 2025 04:51AM Lantheus licenses prostate cancer imaging agent to GE HealthCare for Japan
Sep 24, 2025 01:00AM Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY® (Piflufolastat F 18) in Japan

LNTH and GEHC Related Press Releases

Go Back

Sep 24, 2025 01:00AM Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY® (Piflufolastat F 18) in Japan

LNTH and GEHC Related SEC Filings

Go Back